Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 889 clinical trials
Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury

Radiotherapy, an essential modality in cancer treatment, frequently induces a fibrotic process in the skin which can lead to increased risk of malignancy, poor wound healing, pain and limitation

  • 0 views
  • 23 Jan, 2021
Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction

Skin toxicities are a major complication to cancer therapies. They can be painful and limit the amount of drug that can be received by cancer patients, preventing the patients from receiving

  • 1 views
  • 25 Jan, 2021
  • 2 locations
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients

of the important problems in the field of gastric cancer treatment. With the introduction of minimally invasive treatment concepts and techniques, the role of laparoscopic radical gastrectomy in the

  • 3 views
  • 22 Jan, 2021
  • 1 location
REJOIN Trial for Older Breast Cancer Survivors

) associated with Aromatase Inhibitors (AI) in older breast cancer survivors. Survivors will be recruited from local cancer clinics prior to the completion of primary cancer treatment, as arthralgia can occur

cancer
breast cancer
aromatase inhibitor
  • 0 views
  • 11 Apr, 2021
  • 1 location
High-Dose-Rate Brachytherapy

image-guided (IG) approaches are clinically feasible and could be applied more broadly in prostate cancer therapy.

  • 9 views
  • 18 Apr, 2021
  • 1 location
Atezolizumab and BCG in High Risk BCG na ve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

versus biopsies from primary lesions or metastatic sites. In patients with metastatic bladder cancer, treatment with the PD-L1 inhibitor atezolizumab (1200 mg, every 3 weeks) resulted in objective

bacillus calmette-guerin
carcinoma in situ
carcinoma
bladder cancer
transurethral resection
  • 0 views
  • 25 Jan, 2021
Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Chemotherapy induced peripheral neuropathy (CIPN) is a common side effect of taxanes and platinum derivative based chemotherapeutic agents, common in breast cancer treatment regimens. It can

cancer
taxane
neuralgia
cancer treatment
antineoplastic drugs
  • 0 views
  • 25 Jan, 2021
  • 1 location
Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

This protocol describes a phase II trial investigating the efficacy of CBD in paclitaxel- and oxaliplatin-induced peripheral neuropathy. The trial uses multiple assessments such as validated PRO-questionnaires and multifrequency vibrometry.

  • 0 views
  • 21 Mar, 2021
  • 1 location
A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR). This study will also assess other measures of antitumor activity; overall survival (OS); as well as the safety and tolerability of enfortumab vedotin.

  • 1 views
  • 04 Apr, 2021
  • 30 locations
Hydration Based on Thoitaine Aloe Vera and Calendula in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine

Hand-foot syndrome (HFS) is a very common adverse event of many chemotherapeutic agents, especially capecitabine. The HFS can considerably interfere patient quality of life (QoL). The current treatments for hand-foot symptoms no have demonstrated 100% efficacy. And, the dose reduction and treatment interruption are recommended for treatment of HFS. It …

  • 0 views
  • 12 Apr, 2021
  • 1 location